Argatroban
Argatroban is an intravenous direct thrombin inhibitor used for anticoagulation in patients with heparin-induced thrombocytopenia (HIT) and in certain patients undergoing percutaneous coronary intervention (PCI). It works by directly inhibiting thrombin, preventing the formation of fibrin clots and reducing platelet activation. Argatroban is administered by continuous intravenous infusion under medical supervision, with dosage adjusted according to activated partial thromboplastin time (aPTT) or other appropriate monitoring. The major adverse effect is bleeding, which may range from minor haemorrhage to serious bleeding complications. Liver function should be assessed before and during treatment because hepatic impairment can reduce drug clearance.
Argatroban was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Argatroban, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Argatroban from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Argatroban, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
